News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Philip Ward

Advertisement

Philip Ward is ACT's European editor, phone +44 1244 538583, philipward1@btconnect.com

Articles by Philip Ward

EMA Gives Open Access to Clinical Data on New Medicines

ByPhilip Ward
October 25th 2016

October 25, 2016

EMA Develops Strategy on Adaptive Pathways

ByPhilip Ward
August 5th 2016

August 05, 2016

Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study

ByPhilip Ward
February 19th 2016

February 19, 2016.

Improved Access to Patient Data Holds Key to Future Therapies

ByPhilip Ward
October 22nd 2015

October 22, 2015.

Advertisement

Latest Updated Articles

  • Improved Access to Patient Data Holds Key to Future Therapies
    Improved Access to Patient Data Holds Key to Future Therapies

    October 22nd 2015

  • Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study
    Reporting of Trial Results by Top Academic Centers Remains Poor, Says Study

    February 19th 2016

  • EMA Develops Strategy on Adaptive Pathways
    EMA Develops Strategy on Adaptive Pathways

    August 5th 2016

  • EMA Gives Open Access to Clinical Data on New Medicines
    EMA Gives Open Access to Clinical Data on New Medicines

    October 25th 2016



Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection

2

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals

3

When Ambition Meets Ambiguity: The Trends and Sentiments Shaping Biotech in 2026

4

JCA vs. Reality: Europe’s Push for Clinical Harmonization

5

Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us